Clearside Biomedical Inc (CLSD)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Clearside Biomedical Inc Faces Alarming Losses with Revenue Plummeting to $0.00 Million
Extremely demanding quarter for CLSD in the fourth quarter of 2022
Severe hit for CLSD during the financial interval ending September 30 2022
Shortfall larger than a year before at the company in the second quarter of 2022